Glucuronolactone Market Is Expected To Reach Usd 436.5 Million By 2024 Due To High Demand For Instant Energy Products Till 2024 : Grand View Research, Inc.

 The global glucuronolactonemarket is expected to reach USD 436.5 million by 2024, according to a new report by Grand View Research, Inc. Growing consumer awareness towards the use of glucuronolactone in various food & beverage products including energy drinks and nutrition supplements will augment industry growth over the next eight years. Growing use of the product for manufacturing pharmaceutical drugs and health supplement is expected to fuel industry growth over the forecast period. The positive outlook towards sports nutrition in light of increasing importance of active lifestyle will promote market expansion.

Food & beverage was the prominent end-use segment and was valued at USD 155.1 million in 2015. Rising health conscious population in the urban region is expected to fuel demand growth over the forecast period. Rising disposable income, increasing health awareness, growing population in various countries including the U.S., Brazil, India and China will promote market growth over the upcoming years.

Browse full report by Grand View Research : http://www.grandviewresearch.com/industry-analysis/glucuronolactone-market

Further key findings from the report suggest

·         Pharmaceutical application will witness the fastest growth at a CAGR of 7.0% from 2014 to 2024 as a result of increasing usage of glucuronolactone based tablets and supplements to cure arthritis, hepatocirrhosis, and hepatitis. Furthermore, recovery of pharmaceutical industry in the U.S. is expected to drive market growth over the forecast period.

·         North America glucuronolactone market was valued at USD 106.7 million in 2015 and will show significant rise owing to growing demand for energy drinks and nutritional supplements. Moreover, adoption of glucuronolactone as a supplement is also expected to fuel demand over the forecast period.

·         Asia Pacific will witness significant growth at a CAGR of 6.6% from 2016 to 2024 in light of the high level of glucuronolactone producers in China, India, and Japan with a high level of exports. Moreover, abundant availability of the product in China is expected to have a positive impact on the market over the coming years. Growing pharmaceutical sector in China, India, Indonesia, Malaysia Philippines, Singapore, Thailand and Vietnam will stimulate industry expansion.

·         Key manufacturers & exporters in the global glucuronolactone industry include Aceto Corporation, Anhui Fubore Pharmaceutical & Chemical Co., Ltd., Creative Compounds, LLC, Foodchem International Corporation, Hubei Yitai Pharmaceutical Co., Ltd., Merck Millipore Corporation, and Shaoxing Marina Biotechnology Co., Ltd.

·         Merck Millipore Corporation offers glucuronolactone produced by glucose oxidase and used as a nutritional supplement in pharmaceutical industries.

Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements

Grand View Research has segmented the global glucuronolactone market on the basis of end-use and region:

Global Glucuronolactone End-Use Outlook (Revenue, USD Million, 2013 - 2024)

·         Food & Beverage

·         Pharmaceuticals

·         Others

Global Glucuronolactone Regional Outlook (Revenue, USD Million, 2013 - 2024)

·         North America

o    U.S.

·         Europe

o    Germany

o    UK

o    France

·         Asia Pacific

o    China

o    India

o    Japan

·         Latin America

o    Brazil

·         MEA

View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-glucuronolactone-market

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Inulin Market Is Expected To Grow Due To Dairy Industry Growth Till 2020: Grand View Research ,Inc.

Global inulin market is expected to reach USD 2.35 billion by 2020, according to a new study by Grand View Research, Inc. Gaining popularity of prebiotic ingredients on account of rising awareness towards low fat and calorie reduction is expected to fuel inulin market demand over the next six years. U.S. FDA recognized inulin as generally recognized as safe (GRAS) product, which is expected to have a positive impact on market over the next six years.

Food & beverage was the largest application, accounting for over 65% of market volume in 2013. Inulin is being increasingly used in dairy product formulation such as cheese, spoonable yogurts and butter. Dairy industry growth is expected to act as a major driver for inulin market over the forecast period.

Browse full report by Grand View Research : http://www.grandviewresearch.com/industry-analysis/inulin-market

Further key findings from the study suggest:

·         Global inulin market demand was 246.5 kilo tons in 2013 and is expected to exceed 400 kilo tons by 2020, growing at a CAGR of over 9.0% from 2014 to 2020.

·         Use of inulin in dietary supplements is expected to witness substantial growth over the forecast period. Growing infant formula market demand in China and India coupled with announcement of capacity expansion by baby food manufacturers such as Danone and Nestle is expected to positively impact market over the next six years.

·         Europe was the largest inulin market, accounting for over 50% of global volume in 2013. Regulatory scenario aimed at supporting fortification of food with prebiotic ingredients is expected to fuel inulin demand in the region. Growing demand for substitute prebiotics and development of synbiotics are expected to remain key restraining factors for the market.

·         Asia Pacific is anticipated to witness high at an estimated CAGR of over 10% from 2014 to 2020 in terms of revenue owing to positive dairy industry outlook in India, China, Australia and New Zealand. Gaining popularity of functional foods such as infant formula in China, Japan and India is expected to fuel inulin demand over the forecast period.

·         Global inulin market is highly competitive owing to presence of limited companies. Major market players include Jarrow Formulas, Beneo-Orafti, Sensus and Cosucra. Increasing availability of chicory roots in Belgium, France and Spain has forced inulin manufacturers to establish their facilities in the vicinity. New product development and establishment of strategic partnerships between manufacturers and buyers are expected to remain critical success factors for inulin market over the forecast period.

Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements

Grand View Research has segmented the global inulin market on the basis of application and region:

Global Inulin Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2020)

·         Food & Beverage

·         Dietary Supplements

·         Pharmaceuticals

·         Others

Global Inulin Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2020)

·         North America

·         Europe

·         Latin America

·         Asia Pacific

·         MEA

View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-inulin-market

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Global Carcinoembryonic Antigen (Cea) Expected To Reach Usd 2.56 Billion Due To Increasing Geriatric Population By 2022: Grand View Research, Inc.

Global carcinoembryonicantigen market is expected to reach USD 2.56 Billion by 2022, according to a new study by Grand View Research, Inc. Constant technological advancements pertaining to the development of novel biomarkers which can be used in combination with other biomarkers is expected to boost usage rates over the forecast period. Furthermore, the increasing prevalence of cancer is expected to heighten the demand for effective diagnostic tools. According to the WHO estimates in 2012, global cancer incidences were nearly 14.1 million, which include 6.7 million female patients and 7.4 million male patients. Increasing demand for minimally invasive diagnostics procedures is also expected to play a vital role in determining market growth. Key advantages associated with minimally invasive diagnostics procedures include elevated patient satisfaction levels as they entail minor incision wounds. In addition, these procedures involve relatively lesser hospital stays and therefore, are economically viable and involve fewer post procedure complications.

Browse full report by Grand View Research :http://www.grandviewresearch.com/industry-analysis/carcinoembryonic-antigen-cea-market

Further key findings from the study suggest:

·         Colorectal cancer was one of the largest revenue generating application segment of the carcinoembryonic antigen market and was estimated at USD 639.65 million in 2014. Increasing prevalence of colorectal cancer and usage of carcinoembryonic antigen tests at various stages is one of the critical factors accounting for its large share. For instance, in 2012, new cases of colorectal cancer were estimated to be over 93,000 and death due to colorectal cancer is expected to be over 49,700 in the U.S alone.

·         Carcinoembryonic antigen based breast cancer diagnosis is identified as the most lucrative application segment of the market. The market is driven by factors such as growing number of female population above 50 years, growing demand for Hormone Replacement Therapy (HRT) and cosmetic surgeries. Moreover, growing patient awareness levels and the presence of favorable government initiatives are expected to improve treatment rates over the forecast period.

·         North America was the largest regional market in 2014 owing to, the presence of high incidence rates, presence of favorable reimbursement framework, and high consumer awareness levels coupled with relatively higher healthcare expenditure levels.

·         Asia Pacific is anticipated to witness the most lucrative growth over the forecast period. The presence of untapped opportunities, constantly improving healthcare infrastructure, economic development, and improving patient awareness levels are some factors accounting for this rapid growth.

·         Key players operating in carcinoembryonic antigen market include Abbott Diagnostics, Quest Diagnostics, Roche Diagnostics, GenWay Biotech Inc. and Correlogic Systems, Inc. 

Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the carcinoembryonic antigen market on the basis of application, and region:

Carcinoembryonic Antigen Application Outlook (Revenue, USD Million, 2012 - 2022)

·         Colorectal cancer

·         Pancreatic cancer

·         Ovarian cancer

·         Breast cancer

·         Thyroid cancer

·         Others

Carcinoembryonic Antigen Regional Outlook (Revenue, USD Million, 2012 - 2022)

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    France

o    Spain

·         Asia Pacific

o    China

o    Japan

o    India

·         MEA

o    South Africa

·         Latin America

o    Brazil

o    Mexico

View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-carcinoembryonic-antigen-cea-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Medical Billing Outsourcing Market Expected to Raise Till 2024 : Grand View Research, Inc.

The medical billing outsourcing market was valued at USD 6.3 billion in 2015 and is anticipated to reach a value of USD 16.9billion by 2024, according to a new report by Grand View Research, Inc. Large amount of medical code representation for diagnosis and treatment coupled with the presence of multiple payers renders medical billingan intricate part of any medical practice, posing significant challenges. The challenge mounts when this process mandates adherence to the International Classification of Diseases-10th revision (ICD-10) code along with dealing with rising healthcare costs and declining reimbursements. Challenges in managing in-house billing processes include setbacks experienced in the IT structure, untrained staff, billing errors, and lack of proper financial policy in place. In order to curb or alleviate these challenges, several healthcare providers,such as acute care hospitals and clinics/physician offices, prefer outsourcing their medical billing process. According to studies, in 2015, 95% of independent physicians have acknowledged that outsourcing revenue management is the right decision.

Healthcare providers face certain challenges in ascertaining the disadvantages of in-house operation or benefits of outsourcing revenue management operations;hence, they arrived at this decision by implementing thorough assessment and evaluation of the revenue percentage they spend on several billing operations. Currently, the healthcare system is witnessing a subsequent increase in outsourcing of medical billing services by hospitals and physicians. This increase is attributed to factors such as obligatory implementation of complex ICD-10 coding system, increasing healthcare costs, and federal mandate to implement electronic medical records (EMR) to maintain reimbursement levels.

Furthermore, clinics/physician offices are gradually outsourcing their revenue management to cut unnecessary costs and prevent the burden of managing an administrative team to ensure effectivehandling of in-house billing functions.

Browse full report by Grand View Research : http://www.grandviewresearch.com/industry-analysis/medical-billing-outsourcing-market

Further Key Findings From the Study Suggest:

·         North America reported highest revenue growth in this market. The U.S. is witnessing rapid changes in healthcare structure reflected by implementation of new medical coding system known as the ICD-10 coding as well as pressure from the government to implement EMR management system. These changing regulations coupled with rising healthcare costs are major growth drivers for the market in this region.

·         Multispecialty medical groups are implementing consolidation requiring electronic health record (EHR) integration and building large healthcare networks This integrationcreates a need forRevenue CycleManagement (RCM), which in turn demands additional expertise and trained personnel to manage the same. Consolidation of large healthcare practices is expected to be a one of the factors that will help in the growth of the market.

·         Hospitals end-use segment accounts for the largest market share in the medical billing outsourcing market. The ability to gain total control over billing procedures and minimize loss is the main focus of these providers. As healthcare costs rise and profits are decline, RCMoutsourcing is expected to be the best practice considered by these care facilities to manage their revenue.

·         Some of the key players in this industry include Accretive Health, Inc.; Allscripts; Cerner Corporation; EClinicalWorks; Experian Information Solutions, Inc.; GE Healthcare; Genpact; HCL; Kareo; McKesson Corporation; Quest Diagnostics; and The SSI Group.

Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the medical billing outsourcing market bycomponent, service and end user:

Component Outlook (Revenue, USD Million, 2013 - 2024)

·         In-House

·         Outsourced

Service Outlook (Revenue, USD Million, 2013 - 2024)

·         Front End

·         Middle End

·         Back End

End User Outlook (Revenue, USD Million, 2013 - 2024)

·         Hospitals

·         Physician Offices 

·         Others

Regional Outlook (Revenue, USD Million, 2013 - 2024)

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    UK

·         Asia Pacific

o    Japan

o    India

o    China

·         Latin America

o    Brazil

o    Mexico

·         MEA

o    South Africa

o    Saudi Arabia

View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-medical-billing-outsourcing-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Rehabilitation Equipment Market Expected To Grow Due To Increasing Prevalence Of Non-Communicable Diseases By 2025: Grand View Research, Inc.

The global rehabilitation devices/equipment market is expected to reach USD 17.5 billion by 2025, according to a new report by Grand View Research, Inc. Global increase in prevalence of degenerative diseases and number of trauma cases has led to a rise in number of patients in need of rehabilitation, which is anticipated to boost growth over the forecast period. 

Growing demand for rehabilitation devices in emerging economies is expected to boost the market in regions such as Asia Pacific and Latin America. Strengthened communication between manufacturers and customers due to various strategies employed by manufacturers, government awareness programs, subsidies, and reimbursement programs are few factors anticipated to promote growth.

Mobility equipment was the largest product category in 2016 and is expected to maintain its dominance during the forecast period. This segment held a share of nearly 37.1% in 2016. Exercise equipment segment is expected to witness the strongest growth over the forecast period owing to rise in number of physicians practicing physiotherapy and increase in adoption of physiotherapy in the rehabilitation process.

On the basis of end-use, the hospitals segment held a revenue share of nearly 33.1% in 2016 and is expected to be dominant during the forecast period. Large patient pool of hospitals and rapidly improving rehabilitation centers are amongst key factors attributing to the growth of this segment. Home care settings segment is expected to witness the fastest growth over the forecast period with a CAGR of around 7.4%. Economic benefits of home care over hospitals are primary causes of the anticipated growth. On the basis of geography, North America and Europe accounted for the largest share in 2015, whereas, the Asia Pacific market is expected to grow at a CAGR 8.2% between 2017 and 2025.

Browse full report by Grand View Research : http://www.grandviewresearch.com/industry-analysis/rehabilitation-products-market

Further Key Findings From the Report Suggest:

·         The global rehabilitation devices market size was valued at USD 10.5 billion in 2016 and is expected to grow at a CAGR of 6.0% from 2017 to 2025

·         Mobility equipment was the largest product type segment in 2016 and is estimated to generate revenue over USD 6.7 billion by 2025

·         On the basis of end-use, the market size of hospital segment was valued at USD 3.5 billion in 2016 and is anticipated to witness high growth over the next nine years

·         The U.S. rehabilitation devices market size was valued at USD 2.9 billion in 2016 and is estimated to reach USD 4.4 billion by 2025

·         The rehabilitation equipment market in Asia Pacific is anticipated to witness substantial growth over the next decade owing to various developments taking place in major economies such as China, Japan, and India. The regional market is expected to grow at a CAGR of 8.2% from 2017 to 2025

·         Some players in rehabilitation devices market are Invacare Corporation; Medline Industries, Inc.; Dynatronics Corporation; Drive Devilbiss Healthcare; Esko Bionics; Caremax Rehabilitation Equipment Ltd.; GF Health Products, Inc.; Hospital Equipment Mfg. Co.; Maddak, Inc.; and India Medico Instruments

Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global rehabilitation devices/equipment market on the basis of product, application, end use and region: 

Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Daily Living Aids

o    Medical Beds

o    Bathroom & Toilet Assist Devices

o    Reading Writing & Computer Aids

·         Mobility Equipment

o    Wheelchairs & Scooters

o    Walking Assist Devices

·         Exercise Equipment

o    Lower Body Exercise Equipment

o    Upper Body Exercise Equipment

·         Body Support Devices

o    Patient Lifts

o    Medical Lifting Slings

Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Physiotherapy

·         Occupational Therapy

End Use Outlook (Revenue, USD Million, 2014 - 2025)

·         Hospitals & Clinics

·         Rehab Centers

·         Home Care Settings

·         Physiotherapy Centers

Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    U.K.

·         Asia Pacific

o    China

o    Japan

·         Latin America

o    Brazil

o    Mexico

·         Middle East & Africa

o    South Africa

View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-rehabilitation-devices-equipment-product-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com